[Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation].
Year: 2024
Type: other
Abstract: The combined regimen based on the DAC, VEN, and modified HA regimen showed a high response rate in the salvage therapy for pediatric AML after the relapse of HSCT. However, bridging to transplantation should be performed immediately after remission to result in a long survival rate.
Source: PubMed
Authors: F Zhang, H F Wang, G H Hu, P Suo, L Bai, Y Wang, X H Zhang, X J Huang, Y F Cheng
Institution: Peking University People's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Peking University
OpenAlex ID: W4403515966